SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-105978
Filing Date
2006-05-10
Accepted
2006-05-09 21:35:53
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2006 d10q.htm 10-Q 511728
2 OFFER LETTER BETWEEN THE COMPANY AND MR. ANDREW L. GUGGENHIME dex101.htm EX-10.1 7320
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 5947
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 6026
5 CERTIFICATION BY THE CEO & CFO OF PDL BIOPHARMA, INC. dex321.htm EX-32.1 3526
6 GRAPHIC g51343img001.jpg GRAPHIC 11930
  Complete submission text file 0001193125-06-105978.txt   552622
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 06823150
SIC: 2836 Biological Products, (No Diagnostic Substances)